Primary scale-up bioreactors containing insect cells for the production of VaxSyn, an experimental AIDS vaccine. VaxSyn is based on a genetically-engi

---

Primary scale-up bioreactors containing insect cells for the production of VaxSyn, an experimental AIDS vaccine. VaxSyn is based on a genetically-engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn is genetically- engineered from the baculovirus (an insect virus), with insect cell cultures used in the scale-up process. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection.

---

Size: 5599px × 3711px
Photo credit: © HANK MORGAN/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: aids, bioengineered, bioengineering, bioreactor, biotechnology, drug, drugs, experimental, genetic, genetics, manufacture, pilot, plant, production, vaccine, vaxsyn